These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4976930)

  • 1. [Electrophoretic study of the binding capacity of serum proteins in the diagnosis of thyroid gland diseases].
    Strasek J; Röhling S; Vohnout S
    Cas Lek Cesk; 1969; 108(20):601-4. PubMed ID: 4976930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of levels of protein-bound iodine and free thyroxine-binding protein capacities in vitro during treatment of some thyroid gland diseases].
    Soumar J; Bednár J; Strasek J; Röhling S; Soutorová M
    Vnitr Lek; 1968 Jun; 14(6):588-95. PubMed ID: 4173640
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between the thyroxine-binding capacity of blood proteins and the serum organic iodine level.
    Reviczky AL; Szántó L
    Acta Physiol Acad Sci Hung; 1967; 32(4):337-48. PubMed ID: 4174606
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thyroid and its diseases. Chemical form and clinical significance of thyroid hormones in the serum].
    Inada M
    Naika Hokan; 1971 Oct; 18(10):399-409. PubMed ID: 5004221
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroxine binding globulin (TBG) in thyrotoxicosis and in hypothyroidism.
    Gravina E; Tommaselli A
    Folia Endocrinol; 1972 Apr; 25(2):135-42. PubMed ID: 4125540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative values of protein-bound iodine, the in vitro thyroxine-binding protein capacity and blood cholesterol level in some diseases of the thyroid gland].
    Soumar J; Bednár J; Strasek J
    Endokrinologie; 1967; 52(3):216-27. PubMed ID: 4172943
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro binding of T3 with serum protein in various thyroid diseases].
    Shiomi K
    Nihon Naibunpi Gakkai Zasshi; 1971 Apr; 47(1):69-83. PubMed ID: 4102099
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiopathology of plasmatic transport of thyroid hormones].
    Andreoli M; De Luca F; Negri M; Cramarossa L
    Recenti Prog Med; 1969 Jun; 46(6):507-46. PubMed ID: 4935578
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of serum free thyroxine by RIA in various clinical states.
    Braverman LE; Abreau CM; Brock P; Kleinmann R; Fournier L; Odstrchel G; Schoemaker HJ
    J Nucl Med; 1980 Mar; 21(3):233-9. PubMed ID: 6767812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of free capacities of proteins, binding, in vitro, thyroxine in normal functions and during therapy of diseases of the thyroid gland].
    Soumar J; Strasek J; Röhling S
    Cas Lek Cesk; 1967 Oct; 106(41):1089-93. PubMed ID: 4964941
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of effective thyroxine ratio and free thyroxine in serum.
    Wellby ML; O'Halloran MW; Marshall J
    Clin Chim Acta; 1973 May; 45(3):255-9. PubMed ID: 4196581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin A and carotene in thyroid diseases].
    Smolle J; Wawschinek O; Hayn H; Eber O
    Acta Med Austriaca; 1983; 10(2-3):71-3. PubMed ID: 6880574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free triiodothyronine (FT3) EIA-BioMerieux. Analytical and clinical evaluation.
    Bugugnani MJ; Corbet G; Fleury B; Aubry C
    Ann Biol Clin (Paris); 1993; 51(10-11):871-3. PubMed ID: 8210062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method for the determination of thyroxine-binding protein using a cellulose acetate membrane].
    Maeda R
    Nihon Naibunpi Gakkai Zasshi; 1967 Mar; 42(12):1302-11. PubMed ID: 4166204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the effective Thyroxine Ratio (ETR) test].
    Pohl VG; Galvan G; Maier F; Balke C
    Acta Med Austriaca; 1974; 1(4):122-7. PubMed ID: 4219254
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease.
    Valenta L
    Endocrinol Exp; 1971 Jun; 5(3):127-42. PubMed ID: 5005942
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of thyroid function with hormone assays.
    Liewendahl K
    Ann Chir Gynaecol; 1983; 72(3):84-9. PubMed ID: 6414358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of free thyroxine determinations.
    Kaptein EM
    Clin Lab Med; 1993 Sep; 13(3):653-72. PubMed ID: 8222580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct and indirect parameters for free thyroxine. II. Diagnostic accuracy in disorders of thyroid function and binding protein anomalies].
    Reiners C; Hoffmann R; Moll E; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
    Nuklearmedizin; 1983 Dec; 22(6):273-87. PubMed ID: 6422443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of individual diagnostic tests in the differential diagnosis of thyroid function disorders. VII. TBC index in vitro by diagnostic test Res-O-Mat and electrophoretic test of binding capacity of the serum proteins. Preliminary report on a small number of patients].
    Nĕmec J; Bednár J; Strasek J; Röhling S; Soumar J; Havelka J; Vána S; Zambrazil V
    Cas Lek Cesk; 1972 Feb; 111(5):105-7. PubMed ID: 5012484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.